GGrantIndex
← Leaderboards

Ashish A. Deshmukh

University Of Texas Hlth Sci Ctr Houston

Google Scholar ↗PubMed ↗ORCID ↗
$5,593,211
Attributed
$11,027,721
Total exposure
6
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3M · FY2019–25
$5M$3.8M$2.5M$1.3M$0
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$11,027,721 · 6

By mechanism

R01$10,788,162 · 5
U54$239,559 · 1

Top collaborators

Others in their field

Other Emerging Leaders on “Mortality”

Research focus

MortalityMalignant NeoplasmsNatural HistoryIncidenceMathematical ModelHuman PapillomavirusScreeningCost EffectivenessSquamous Intraepithelial LesionWomanCost EffectiveMalignant Neoplasm Of Cervix UteriCohortModels And SimulationPersonsDiagnosisClinical TrialsFutureCervical Cancer ScreeningAdoptionTreatment OutcomeMorbidity - Disease RateGuidelinesAnus

Grant awards (22)

The effectiveness of screening women with lower genital tract neoplasia or cancers for anal cancer precursors$1,106,183
R01 · FY2025 · CA
Optimizing Treatment of Prostate Cancer in Men living with HIV$669,481
R01 · FY2025 · CA
Optimizing Treatment for Human Papillomavirus-Associated Oropharyngeal Cancer in Older Adults$629,179
R01 · FY2025 · CA · contact PI
The effectiveness, cost-effectiveness, and budget impact of interventions to improve the delivery of cervical cancer screening in Puerto Rico.$560,185
R01 · FY2025 · CA
The effectiveness, cost-effectiveness, and budget impact of interventions to improve the delivery of cervical cancer screening in Puerto Rico.$44,843
R01 · FY2025 · CA
Optimizing Treatment of Prostate Cancer in Men living with HIV$669,206
R01 · FY2024 · CA
The effectiveness of screening women with lower genital tract neoplasia or cancers for anal cancer precursors$566,629
R01 · FY2024 · CA
The effectiveness, cost-effectiveness, and budget impact of interventions to improve the delivery of cervical cancer screening in Puerto Rico.$542,687
R01 · FY2024 · CA
The effectiveness, cost-effectiveness, and budget impact of interventions to improve the delivery of cervical cancer screening in Puerto Rico.$50,587
R01 · FY2024 · CA
Survivorship and cost of care of cervical cancer patients in Puerto Rico in association with cervical cancer screening$26,422
R01 · FY2024 · CA
The effectiveness of screening women with lower genital tract neoplasia or cancers for anal cancer precursors$844,362
R01 · FY2023 · CA
Optimizing Treatment of Prostate Cancer in Men living with HIV$720,465
R01 · FY2023 · CA
The effectiveness, cost-effectiveness, and budget impact of interventions to improve the delivery of cervical cancer screening in Puerto Rico.$566,891
R01 · FY2023 · CA
The effectiveness of screening women with lower genital tract neoplasia or cancers for anal cancer precursors$843,841
R01 · FY2022 · CA
Optimizing Age-based Anal Cancer Screening Among People Living with HIV using Decision Analytic Modeling$488,913
R01 · FY2022 · CA · contact PI
Optimizing Age-based Anal Cancer Screening Among People Living with HIV using Decision Analytic Modeling$1
R01 · FY2022 · CA · contact PI
The effectiveness of screening women with lower genital tract neoplasia or cancers for anal cancer precursors$916,003
R01 · FY2021 · CA
Optimizing Age-based Anal Cancer Screening Among People Living with HIV using Decision Analytic Modeling$490,571
R01 · FY2021 · CA · contact PI
Full Project 2: Determining Optimal Anal Cancer Prevention Strategies for HIV-Infected Individuals Living in Puerto Rico$115,793
U54 · FY2021 · CA · contact PI
Optimizing Age-based Anal Cancer Screening Among People Living with HIV using Decision Analytic Modeling$500,531
R01 · FY2020 · CA · contact PI
Full Project 2: Determining Optimal Anal Cancer Prevention Strategies for HIV-Infected Individuals Living in Puerto Rico$123,766
U54 · FY2020 · CA · contact PI
Optimizing Age-based Anal Cancer Screening Among People Living with HIV using Decision Analytic Modeling$551,182
R01 · FY2019 · CA · contact PI